litlas
Log inCreate account

Michael H. Davidson

Active 1977–2025

Also published as
Michael H Davidson
137
Papers
26,572
Citations
92
h-index
132
i10-index

Citations

Citations per year for Michael H. Davidson1964: 1 citations1976: 2 citations1978: 2 citations1979: 1 citations1981: 1 citations1985: 1 citations1986: 1 citations1991: 2 citations1992: 1 citations1994: 2 citations1995: 3 citations1996: 14 citations1997: 25 citations1998: 36 citations1999: 35 citations2000: 47 citations2001: 60 citations2002: 66 citations2003: 110 citations2004: 133 citations2005: 137 citations2006: 159 citations2007: 188 citations2008: 259 citations2009: 247 citations2010: 194 citations2011: 278 citations2012: 209 citations2013: 215 citations2014: 203 citations2015: 231 citations2016: 254 citations2017: 192 citations2018: 206 citations2019: 627 citations2020: 631 citations2021: 508 citations2022: 481 citations2023: 387 citations2024: 620 citations2025: 305 citations2026: 17 citations1965–1975: no citations, so these years are not shown1977: no citations, so this year is not shown1980: no citations, so this year is not shown1982–1984: no citations, so these years are not shown1987–1990: no citations, so these years are not shown1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,717 citing papers, 26.1% of this breakdownUnited Kingdom: 745 citing papers, 7.1% of this breakdownChina: 659 citing papers, 6.3% of this breakdownCanada: 530 citing papers, 5.1% of this breakdownItaly: 481 citing papers, 4.6% of this breakdownGermany: 433 citing papers, 4.2% of this breakdownAustralia: 425 citing papers, 4.1% of this breakdownNetherlands: 376 citing papers, 3.6% of this breakdownFrance: 261 citing papers, 2.5% of this breakdownJapan: 240 citing papers, 2.3% of this breakdownSpain: 237 citing papers, 2.3% of this breakdownSweden: 204 citing papers, 2% of this breakdown
0%26.1%Other 29.8%

Institutions

Fields

  • Medicine67.8%
  • Biochemistry, Genetics and Molecular Biology13%
  • Nursing10.2%
  • Immunology and Microbiology2.3%
  • Agricultural and Biological Sciences1.7%
  • Neuroscience1%
  • Other4%

Topics

  • Lipoproteins and Cardiovascular Health12.4%
  • Diabetes, Cardiovascular Risks, and Lipoproteins7.8%
  • Fatty Acid Research and Health3.6%
  • Cancer, Lipids, and Metabolism3.3%
  • Cholesterol and Lipid Metabolism2.5%
  • Lipid metabolism and disorders1.8%
  • Other68.6%

Coauthors

All papers

Open in search
  1. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk

    Authors: Stephen J. Nicholls, A. Michael Lincoff, Michelle Garcia, Dianna Bash, Christie M. Ballantyne, Philip J. Barter, Michael H. Davidson, John J.P. Kastelein, Wolfgang Köenig, Darren K. McGuire, Dariush Mozaffarian, Paul M. Ridker, Kausik K. Ray, Brian G. Katona, Anders Himmelmänn, Larrye E. Loss, Martin Rensfeldt, Torbjörn Lundström, Rahul Agrawal, Venu Menon, Kathy Wolski, Steven E. Nissen - JAMA 2020 cited by 982

  2. Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial

    Authors: Stephen J. Nicholls, Marc Ditmarsch, John J.P. Kastelein, Scott P. Rigby, Douglas Kling, Danielle Curcio, Nicholas John, Michael H. Davidson - Nature Medicine 2022 cited by 169

  3. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease

    Authors: Paul S. Jellinger, Yehuda Handelsman, Paul D. Rosenblit, Zachary T. Bloomgarden, Vivian Fonseca, Alan J. Garber, George Grunberger, Chris Guerin, David S.H. Bell, Jeffrey I. Mechanick, Rachel Pessah‐Pollack, Kathleen Wyne, Donald A. Smith, Eliot A. Brinton, Sergio Fazio, Michael H. Davidson, Paul S. Jellinger, Yehuda Handelsman, David S.H. Bell, Zachary T. Bloomgarden, Eliot A. Brinton, Michael H. Davidson, Sergio Fazio, Vivian Fonseca, Alan J. Garber, George Grunberger, Chris Guerin, Jeffrey I. Mechanick, Rachel Pessah‐Pollack, Paul D. Rosenblit, Donald A. Smith, Kathleen Wyne, Michael A. Bush, Farhad Zangeneh, Yehuda Handelsman, David S.H. Bell, Zachary T. Bloomgarden, Eliot A. Brinton, Sergio Fazio, Vivian Fonseca, Alan J. Garber, George Grunberger, Chris Guerin, Paul S. Jellinger, Paul D. Rosenblit, Donald A. Smith, Kathleen Wyne, Michael H. Davidson - Endocrine Practice 2017 cited by 1,098

  4. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm – 2020 Executive Summary

    Authors: Yehuda Handelsman, Paul S. Jellinger, Chris Guerin, Zachary T. Bloomgarden, Eliot A. Brinton, Matthew J. Budoff, Michael H. Davidson, Daniel Einhorn, Sergio Fazio, Vivian Fonseca, Alan J. Garber, George Grunberger, Ronald M. Krauss, Jeffrey I. Mechanick, Paul D. Rosenblit, Donald A. Smith, Kathleen Wyne - Endocrine Practice 2020 cited by 248

  5. Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial

    Authors: Christie M. Ballantyne, Marc Ditmarsch, John J.P. Kastelein, Adam J. Nelson, Douglas Kling, Andrew Hsieh, Danielle Curcio, Kevin C. Maki, Michael H. Davidson, Stephen J. Nicholls - Journal of clinical lipidology 2023 cited by 81

  6. Partitioning Heritability of Regulatory and Cell-Type-Specific Variants across 11 Common Diseases

    Authors: Alexander Gusev, Sang Lee, Gosia Trynka, Hilary K. Finucane, Bjarni J. Vilhjálmsson, Han Xu, Chongzhi Zang, Stephan Ripke, Brendan Bulik‐Sullivan, Eli A. Stahl, Anna K. Kähler, Christina M. Hultman, Shaun Purcell, Steven A. McCarroll, Mark J. Daly, Bogdan Paşaniuc, Patrick F. Sullivan, Benjamin M. Neale, Naomi R. Wray, Soumya Raychaudhuri, Alkes L. Price, Stephan Ripke, Benjamin M. Neale, Aiden Corvin, James Walters, Kai-How Farh, Peter Holmans, Phil Lee, Brendan Bulik‐Sullivan, David Collier, Hailiang Huang, Tune H. Pers, Ingrid Agartz, Esben Agerbo, Margot Albus, Madeline Alexander, Farooq Amin, Silviu‐Alin Bacanu, Martin Begemann, Richard A. Belliveau, Judit Bene, Sarah E. Bergen, Elizabeth Bevilacqua, Tim B. Bigdeli, Donald W. Black, Anders D. Børglum, Richard Bruggeman, Nancy G. Buccola, Randy L. Buckner, William Byerley, Wiepke Cahn, Guiqing Cai, Dominique Campion, Rita M. Cantor, Vaughan J. Carr, Noa Carrera, Stanley V. Catts, Kimberly D. Chambert, Raymond Chan, Ronald Y.L. Chen, Eric Chen, Wei Cheng, Eric Cheung, Siow Ann Chong, C. Robert Cloninger, David Cohen, Nadine Cohen, Paul Cormican, Nick Craddock, James J. Crowley, David Curtis, Michael H. Davidson, Kenneth L. Davis, Franziska Degenhardt, Jurgen Del‐Favero, Lynn E. DeLisi, Ditte Demontis, Dimitris Dikeos, Timothy G. Dinan, Srdjan Djurovic, Gary Donohoe, Elodie Drapeau, Jubao Duan, Frank Dudbridge, Naser Durmishi, Peter Eichhammer, Johan G. Eriksson, Valentina Escott‐Price, Laurent Essioux, Ayman H. Fanous, Martilias S. Farrell, Josef Frank, Lude Franke, Robert Freedman, Nelson B. Freimer, Marion Friedl, Joseph I. Friedman, Menachem Fromer, Giulio Genovese, Lyudmila Georgieva and 245 more - The American Journal of Human Genetics 2014 cited by 654

  7. Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments

    Authors: John J.P. Kastelein, Andrew Hsieh, Mary R. Dicklin, Marc Ditmarsch, Michael H. Davidson - Current Atherosclerosis Reports 2023 cited by 62

  8. Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels

    Authors: Adam J. Nelson, Allan D. Sniderman, Marc Ditmarsch, Mary R. Dicklin, Stephen J. Nicholls, Michael H. Davidson, John J.P. Kastelein - International Journal of Molecular Sciences 2022 cited by 71

  9. Effect of CC Chemokine Receptor 2 CCR2 Blockade on Serum C-Reactive Protein in Individuals at Atherosclerotic Risk and With a Single Nucleotide Polymorphism of the Monocyte Chemoattractant Protein-1 Promoter Region

    Authors: Jim Gilbert, Julie Lekstrom-Himes, Debra D. Donaldson, Yih Lee, Mingxiu Hu, Jing Xu, Tim Wyant, Michael H. Davidson - The American Journal of Cardiology 2011 cited by 181

  10. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety

    Authors: Eli M. Roth, Michael H. Davidson - Reviews in Cardiovascular Medicine 2018 cited by 82

  11. Association of Interleukin 6 Inhibition With Ziltivekimab and the Neutrophil-Lymphocyte Ratio

    Authors: Nicholas H. Adamstein, Jan H. Cornel, Michael H. Davidson, Peter Libby, Alessandra De Remigis, Camilla Jensen, Kathrine Ekström, Paul M. Ridker - JAMA Cardiology 2022 cited by 56

  12. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial)

    Authors: Peter H. Jones, Michael H. Davidson, Evan A. Stein, Harold Bays, James M. McKenney, Elinor Miller, Valerie A. Cain, James W. Blasetto - The American Journal of Cardiology 2003 cited by 1,403

  13. Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group

    Authors: Peter W.F. Wilson, Terry A. Jacobson, Seth S. Martin, Elizabeth J. Jackson, Ngoc‐Anh Le, Michael H. Davidson, Hubert W. Vesper, Ruth Frikke‐Schmidt, Christie M. Ballantyne, Alan T. Remaley - Journal of clinical lipidology 2021 cited by 134

  14. Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk

    Authors: Stephen J. Nicholls, Adam J. Nelson, Marc Ditmarsch, John J.P. Kastelein, Christie M. Ballantyne, Kausik K. Ray, Ann Marie Návar, Steven E. Nissen, Mariko Harada‐Shiba, Danielle Curcio, Annie Neild, Douglas Kling, Andrew Hsieh, Julie Butters, Brian A. Ference, Ulrich Laufs, Maciej Banach, Roxana Mehran, Alberico L. Catapano, Yong Huo, Michael Szarek, Violeta Balinskaite, Michael H. Davidson - New England Journal of Medicine 2025 cited by 83

  15. Obicetrapib on top of maximally tolerated lipid‐modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN

    Authors: Stephen J. Nicholls, Adam J. Nelson, Marc Ditmarsch, John J.P. Kastelein, Christie M. Ballantyne, Kausik K. Ray, Ann Marie Návar, Steven E. Nissen, Anne C. Golberg, Liam R. Brunham, Danielle Curcio, Erin Wuerdeman, Annie Neild, Douglas Kling, Andrew Hsieh, Mary R. Dicklin, Brian A. Ference, Ulrich Laufs, Maciej Banach, Roxana Mehran, Alberico L. Catapano, Michael H. Davidson - American Heart Journal 2024 cited by 44

  16. Inhibition of oxidized low-density lipoprotein with orticumab inhibits coronary inflammation and reduces residual inflammatory risk in psoriasis: a pilot randomized, double-blind placebo-controlled trial

    Authors: Christopher Farina, Michael H. Davidson, Prediman K. Shah, Charles W. Stark, Wenqi Lu, Cheerag Shirodaria, Timothy Wright, Charalambos Antoniades, Jan Nilsson, Nehal N. Mehta - Cardiovascular Research 2024 cited by 30

  17. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes

    Authors: S. Kodali, Philippe Pîbarot, Pamela S. Douglas, Mathew Williams, Ke Xu, Vinod H. Thourani, Charanjit S. Rihal, Alan Zajarías, Darshan Doshi, Michael H. Davidson, E. Murat Tuzcu, William C. Stewart, Neil J. Weissman, Lars G. Svensson, Kevin L. Greason, Hersh S. Maniar, Michael J. Mack, Saif Anwaruddin, M. B. Leon, Rebecca T. Hahn - European Heart Journal 2014 cited by 439

  18. Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease

    Authors: Robert S. Rosenson, Michael H. Davidson, Benjamin J. Hirsh, Sekar Kathiresan, Daniel Gaudet - Journal of the American College of Cardiology 2014 cited by 260

  19. Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk

    Authors: Gregory S. Thomas, William C. Cromwell, Shariq Ali, Wai Chin, JoAnn Flaim, Michael H. Davidson - Journal of the American College of Cardiology 2013 cited by 246

  20. ω-6 Polyunsaturated Fatty Acids and Cardiometabolic Health: Current Evidence, Controversies, and Research Gaps

    Authors: Kevin C. Maki, Fulya Eren, Martha E Cassens, Mary R. Dicklin, Michael H. Davidson - Advances in Nutrition 2018 cited by 123

  21. The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study

    Authors: Michael H. Davidson, Michael Stevenson, Andrew Hsieh, Zahid Ahmad, Jeanine E. Roeters van Lennep, Caroline Crowson, Joseph L. Witztum - Journal of clinical lipidology 2018 cited by 83

  22. A method for separating the granulosa cells, the basal lamina and the theca of the preovulatory ovarian follicle of the domestic fowl ( Gallus domesticus )

    Authors: A. B. Gilbert, Anthony J. Evans, Margaret M. Perry, Michael H. Davidson - Reproduction 1977 cited by 388

  23. Safety Considerations with Fibrate Therapy

    Authors: Michael H. Davidson, Annemarie Armani, James M. McKenney, Terry A. Jacobson - The American Journal of Cardiology 2006 cited by 408

  24. Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

    Authors: Maciej Banach, Manfredi Rizzo, Peter P. Tóth, Michel Farnier, Michael H. Davidson, Khalid Al‐Rasadi, Wilbert S. Aronow, Vasilios G. Athyros, Dragan Djurić, М. В. Ежов, Robert S. Greenfield, G. Kees Hovingh, Karam Kostner, Corina Serban, Daniel Lighezan, Zlatko Fras, Patrick M. Moriarty, Paul Muntner, Assen Goudev, R Češka, Stephen J. Nicholls, Marlena Broncel, Dragana Nikolić, Daniel Pella, Raman Puri, Jacek Rysz, Nathan D. Wong, László Bajnok, Steven R. Jones, Kausik K. Ray, Dimitri P. Mikhailidis - Archives of Medical Science 2015 cited by 385